Literature DB >> 2807527

Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.

H Moll1, G F Mitchell, M J McConville, E Handman.   

Abstract

We have previously reported that a Leishmania major lipophosphoglycan (LPG), given with killed Corynebacterium parvum as an adjuvant, can vaccinate mice against cutaneous leishmaniasis. In order to analyze whether T cells are able to recognize this important parasite antigen, we have studied both humoral and cellular immune responses to L. major LPG that had been isolated from promastigotes by sequential solvent extraction and hydrophobic chromatography. The data show that immunization of mice with highly purified LPG induced an increase in frequency of L. major-reactive T cells and the production of immunoglobulin G antibodies to LPG. Furthermore, genetically resistant mice infected with L. major were able to develop a specific delayed-type hypersensitivity response in the ear to L. major LPG. These findings strongly suggest that T cells can recognize and respond to glycolipid antigens, in this case a host-protective Leishmania LPG, even though such antigens appear not to be potent T-cell stimulators in mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807527      PMCID: PMC259819          DOI: 10.1128/iai.57.11.3349-3356.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

Review 2.  Immunization against tuberculosis: what kind of vaccine?

Authors:  A J Crowle
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

3.  Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.

Authors:  D Frommel; B W Ogunkolade; I Vouldoukis; L Monjour
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

4.  Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets.

Authors:  R M Locksley; F P Heinzel; M D Sadick; B J Holaday; K D Gardner
Journal:  Ann Inst Pasteur Immunol       Date:  1987 Sep-Oct

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

Review 7.  Thymocyte subpopulations: an experimental review, including flow cytometric cross-correlations between the major murine thymocyte markers.

Authors:  R Scollay; K Shortman
Journal:  Thymus       Date:  1983-09

8.  Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain.

Authors:  J A Robertsson; S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  In vitro T cell-mediated killing of Pseudomonas aeruginosa. V. Generation of bactericidal T cells in nonresponder mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

10.  Cellular immunity to Bacteroides fragilis capsular polysaccharide.

Authors:  M E Shapiro; A B Onderdonk; D L Kasper; R W Finberg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  13 in total

1.  Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.

Authors:  A A Izzo; B P Marmion; T Hackstadt
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides.

Authors:  G Y Ishioka; A G Lamont; D Thomson; N Bulbow; F C Gaeta; A Sette; H M Grey
Journal:  Springer Semin Immunopathol       Date:  1993

Review 3.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

4.  The preparation of neoglycoconjugates containing inter-saccharide phosphodiester linkages as potential anti-Leishmania vaccines.

Authors:  F H Routier; A V Nikolaev; M A Ferguson
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

5.  Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).

Authors:  S C Mendonça; D G Russell; S G Coutinho
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

6.  Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani.

Authors:  D L Tolson; S J Turco; T W Pearson
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 7.  Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.

Authors:  A V Nikolaev; O V Sizova
Journal:  Biochemistry (Mosc)       Date:  2011-07       Impact factor: 2.487

8.  Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis.

Authors:  L Morris; A B Troutt; K S McLeod; A Kelso; E Handman; T Aebischer
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.

Authors:  D L Tolson; A Jardim; L F Schnur; C Stebeck; C Tuckey; R P Beecroft; H S Teh; R W Olafson; T W Pearson
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan.

Authors:  Joseph L Amprey; Jin S Im; Salvatore J Turco; Henry W Murray; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli; Gerald F Späth
Journal:  J Exp Med       Date:  2004-10-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.